WATER IV PCa (AS Sub-study)

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Trial Details

NCT ID
NCT07650448
Phase
NA
Sponsor
PROCEPT BioRobotics
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Aquablation Therapy
  • Active Surveillance
Locations (sample)
  • Chandler, Arizona, United States|33.30616,-111.84125
  • Los Angeles, California, United States|34.05223,-118.24368
  • Murrieta, California, United States|33.55391,-117.21392
  • Boulder, Colorado, United States|40.01499,-105.27055
  • Delray Beach, Florida, United States|26.46146,-80.07282

Key Eligibility Criteria

  • Biological male with age ≥ 45 years at the time of consent
  • Biopsy positive Grade Group 2 prostate cancer or biopsy positive Grade Group 1 MRI visible lesion (PI-RADS/Likert ≥ 3)
  • First prostate cancer diagnoses within 18 months (545 days) of consent
  • Are candidates for active surveillance

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →